Blue Chip Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$865K Buy
1,959
+1
+0.1% +$413 0.68% 37
2020
Q2
$710K Buy
1,958
+30
+2% +$10.1K 0.67% 42
2020
Q1
$547K Sell
1,928
-400
-17% -$126K 0.68% 41
2019
Q4
$756K Buy
2,328
+31
+1% +$9.4K 0.7% 41
2019
Q3
$669K Buy
2,297
+65
+3% +$18.6K 0.7% 43
2019
Q2
$655K Buy
2,232
+76
+4% +$20.9K 0.69% 44
2019
Q1
$590K Buy
2,156
+1
+0% +$249 0.67% 45
2018
Q4
$482K Buy
2,155
+1
+0% +$235 0.63% 47
2018
Q3
$526K Buy
2,154
+451
+26% +$104K 0.53% 53
2018
Q2
$353K Buy
1,703
+101
+6% +$21.4K 0.38% 69
2018
Q1
$331K Buy
+1,602
New +$336K 0.34% 68

Other funds holding TMO

Blue Chip Wealth Management's TMO Position: Q3 2020 in Review

Blue Chip Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 0.05% in Q3 2020, buying an estimated $413 and bringing the position to 1,959 shares worth $865K. The position accounts for 0.68% of the portfolio, ranked #37.

Blue Chip Wealth Management first reported a position in TMO in Q1 2018 and has held it in 11 quarters since. 1,847 funds tracked by Wall St. Rank hold TMO as of Q3 2020.

  • Blue Chip Wealth Management held 1,959 shares of Thermo Fisher Scientific worth $865K as of Q3 2020.
  • Blue Chip Wealth Management bought 1 Thermo Fisher Scientific share in Q3 2020, an estimated $413.
  • Thermo Fisher Scientific made up 0.68% of Blue Chip Wealth Management's portfolio in Q3 2020, its #37 holding.
  • Blue Chip Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 11 quarters since.
  • 1,847 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2020.

Based on Blue Chip Wealth Management's 13F filing for Q3 2020, filed 12 Nov 2020.